120 related articles for article (PubMed ID: 38651381)
1. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
3. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.
Thomas E; Colombeau L; Gries M; Peterlini T; Mathieu C; Thomas N; Boura C; Frochot C; Vanderesse R; Lux F; Barberi-Heyob M; Tillement O
Int J Nanomedicine; 2017; 12():7075-7088. PubMed ID: 29026302
[TBL] [Abstract][Full Text] [Related]
6. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
[TBL] [Abstract][Full Text] [Related]
7. A Cell Membrane-Targeting Self-Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback.
Ma W; Sha SN; Chen PL; Yu M; Chen JJ; Huang CB; Yu B; Liu Y; Liu LH; Yu ZQ
Adv Healthc Mater; 2020 Jan; 9(1):e1901100. PubMed ID: 31763796
[TBL] [Abstract][Full Text] [Related]
8. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
[TBL] [Abstract][Full Text] [Related]
10. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy.
Guo D; Xu S; Wang N; Jiang H; Huang Y; Jin X; Xue B; Zhang C; Zhu X
Biomaterials; 2017 Nov; 144():188-198. PubMed ID: 28837960
[TBL] [Abstract][Full Text] [Related]
11. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
Bhuvaneswari R; Gan YY; Lucky SS; Chin WW; Ali SM; Soo KC; Olivo M
Mol Cancer; 2008 Jun; 7():56. PubMed ID: 18549507
[TBL] [Abstract][Full Text] [Related]
13. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
14. Aggregation-Induced Emission Photosensitizer-Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy.
Yu B; Liu M; Jiang L; Xu C; Hu H; Huang T; Xu D; Wang N; Li Q; Tang BZ; Huang X; Zhang W
Adv Healthc Mater; 2024 Apr; 13(11):e2303643. PubMed ID: 38115727
[TBL] [Abstract][Full Text] [Related]
15. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
16. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ
Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
19. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.
Duanmu J; Cheng J; Xu J; Booth CJ; Hu Z
Br J Cancer; 2011 Apr; 104(9):1401-9. PubMed ID: 21427724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
